Vaxneuvance

Vaxneuvance is a medicine authorised by Swissmedic under authorisation number 68752. The authorisation holder is MSD Merck Sharp & Dohme AG. The medicinal product code is Vaccines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 February 2023 and the authorisation is limited until 13 February 2028. ATC code J07AL02 places the medicine in the group Vaccines.

  • Dispensing category B
  • Authorisation number 68752
  • ATC J07AL02
  • Vaccines
Authorisation data
Authorisation number68752
NameVaxneuvance
Full nameVaxneuvance, Injektionssuspension
Authorisation holderMSD Merck Sharp & Dohme AG
Medicinal product codeVaccines
Dispensing categoryB · Prescription only
ATC codeJ07AL02
First authorisation14 February 2023
Authorisation validity13 February 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Vaxneuvance, InjektionssuspensionB14 February 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)J07AL0208.08.B
210Fertigspritze(n)J07AL0208.08.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Vaxneuvance authorised in Switzerland?

Yes. Vaxneuvance is authorised by Swissmedic under authorisation number 68752, data as of 01 September 2026. The authorisation is limited until 13 February 2028.

Which dispensing category does Vaxneuvance have?

Vaxneuvance is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Vaxneuvance?

The authorisation holder is MSD Merck Sharp & Dohme AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com